(Q48318477)

10 February 2018

title

Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas. (English)

1 reference

10 February 2018

author name string

Yanyang Tu

1

1 reference

10 February 2018

Yuexia Zhong

2

1 reference

10 February 2018

Jianfang Fu

3

1 reference

10 February 2018

Yizhan Cao

4

1 reference

10 February 2018

Guoqiang Fu

5

1 reference

10 February 2018

Xiaoxi Tian

6

1 reference

10 February 2018

Boliang Wang

7

1 reference

10 February 2018

publication date

5 February 2010

1 reference

10 February 2018

published in

Medical Oncology

1 reference

10 February 2018

volume

28

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

15-23

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s12032-010-9435-1

exact match

0 references

cites work

The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

STAT proteins: From normal control of cellular events to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Activation of STAT proteins and growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

STAT signalling in cell proliferation and in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Quantitatively determined survivin expression levels are of prognostic value in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Shaping gene expression in activated and resting primary macrophages by IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

STAT3 activation in macrophages following infection with Salmonella.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Activation of stat3 in human melanoma promotes brain metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9435-1

Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20135364

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20135364

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

World Health Organization classification of tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20135364

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-010-9435-1

1 reference

10 February 2018

PubMed ID

20135364

1 reference

10 February 2018